Paranovus Entertainment Technology Ltd. (PAVS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
PAVS currently has 66.7M outstanding shares. with significant dilution risk as 44.4M authorized shares could dilute existing holders by 66.5%. The company has significantly diluted shareholders by 10798.18% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 25, 2025 |
F-3 filing: Paranovus Entertainment Technology Ltd. is offering Class A Ordinary Shares, Preferred Shares, Debt Securities, Warrants, Rights and Units for a total aggregate amount of $200,000,000. |
67M | 44M |
| Aug 04, 2025 |
20-F filing | 66.7M shares outstanding |
67M | 44M |
| Sep 13, 2024 |
F-3 filing: This is an F-3 filing for a shelf offering of Class A Ordinary Shares by selling shareholders. |
610K | 110M |
| Aug 01, 2024 |
20-F filing | 0.6M shares outstanding |
610K | 110M |
| Nov 16, 2023 |
F-3 filing: Paranovus Entertainment Technology Ltd. may offer and sell up to $100,000,000 in the aggregate of Class A ordinary shares, preferred shares, warrants, units and rights to purchase Class A Ordinary Shares or preferred shares, debt securities, rights or any combination of the foregoing. |
7.7M | 100M |
| Jul 27, 2023 |
20-F filing | 7.7M shares outstanding |
7.7M | 59M |
| Aug 15, 2022 |
20-F filing | 66.9M shares outstanding |
67M | 0 |
| Aug 02, 2021 |
20-F filing | 32.0M shares outstanding |
32M | 35M |
| Nov 12, 2020 |
F-3 filing: Happiness Biotech Group Limited is filing an F-3 to offer and sell up to $80,000,000 in the aggregate of Ordinary Shares, preferred shares, warrants to purchase Ordinary Shares or preferred shares, debt securities, rights or any combination of the foregoing. |
23M | 43M |
| Jul 24, 2020 |
20-F filing | 23.0M shares outstanding |
23M | 0 |